Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care

 Lilly and T1D Exchange Announce Research Collaboration to Inform Development
                 of New Initiatives to Advance Diabetes Care

Research Projects Will Use Real-World Evidence to Support People Living With
Type 1 Diabetes

PR Newswire

BOSTON and INDIANAPOLIS, April 9, 2014

BOSTON and INDIANAPOLIS, April 9, 2014 /PRNewswire/ --T1D Exchange and Eli
Lilly and Company (NYSE: LLY) announced today they have entered into a
research collaboration that will enable both organizations to gain deeper,
real-world insight about the experience of people with type 1 diabetes, to
identify new ways to improve care and advance outcomes.

As part of this multi-year collaboration, the organizations will engage in a
range of projects that combine Lilly's long history of and expertise in type 1
diabetes with T1D Exchange's innovative, patient-centric model that connects a
clinic registry of more than 26,000 people with T1D, a clinic network
comprised of more than 70 clinics across the U.S., a sample repository that
stores patient biosamples and Glu, a patient and caregiver online community
for T1D. The collaboration will involve multiple projects over an initial
five-year period.

"Lilly's commitment to supporting people with type 1 diabetes dates back to
1923, when we introduced the first commercially available insulin," said Dara
Schuster, M.D., Medical Fellow, Lilly Diabetes. "Having access to the
resources of T1D Exchange to bolster our understanding of the needs of people
with type 1 diabetes, their caregivers and health care providers will help us
continue our mission of addressing the global diabetes burden through the
development of innovative medicines and programs."

The first project of the collaboration will assess user experience associated
with insulin pumps and multiple daily injections. Initially, T1D Exchange data
will be analyzed to inform development of a survey of health care providers
from the clinic network and members of the Glu community. Following the
survey, a study of clinic registry participants is planned, to further shed
light on how insulin pumps are used and how multiple daily injections occur in
real-world practice. Data and recommendations from this research will be
shared publicly once analysis is complete, for the benefit of both the type 1
diabetes and researcher communities.

"The T1D Exchange Clinic Registry was established to provide real-world data
on a large number of children and adults with type 1 diabetes to serve as a
resource for both academic and company researchers," said Dr. Roy Beck,
Director, T1D Exchange Clinic Coordinating Center, Executive Director, JAEB
Center for Health Research."This collaboration with Lilly is a great example
of how the registry data can be used to address key issues that are important
to individuals with type 1 diabetes."

About T1D Exchange
T1D Exchange, the first program of Unitio, was founded on the premise that
finding faster, better therapies for type 1 diabetes (T1D) requires a research
model as multi-faceted as the disease itself. T1D Exchange acts as a convener
of the thousands of people working to improve patient outcomes already—by
connecting them to one another and to the patient community at large. Drawing
on decades of research and data that have come before, T1D Exchange aims to be
the translational engine that enables the entire T1D ecosystem to collaborate
in truly novel ways via the integration of a Clinic Network, Clinic Registry,
Sample Repository, and the online patient/caregiver community, Glu. For more
information, please visit

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make
life better for people around the world. We were founded more than a century
ago by a man committed to creating high-quality medicines that meet real
needs, and today we remain true to that mission in all our work. Across the
globe, Lilly employees work to discover and bring life-changing medicines to
those who need them, improve the understanding and management of disease, and
give back to communities through philanthropy and volunteerism. To learn more
about Lilly, please visit us at and



Tracy McMahon
T1D Exchange

Julie Williams
Eli Lilly and Company

Eli Lilly and Company logo

T1D Exchange

Photo -

SOURCE Eli Lilly and Company

Press spacebar to pause and continue. Press esc to stop.